Why Nonacus?
Our core values stem from being patient and customer centric, collaborative and innovative in our approach. As a company, we strive to deliver innovative genomic technologies which advance liquid biopsy diagnostics and improve cancer patient outcomes worldwide.
Find out more about our mission and vision.
A Deloitte Tech Fast 50 winner 2022
Nonacus was recently announced as one of the top three fastest-growing technology companies in the UK, and the fastest in healthcare. This accolade provides just one example of our drive to democratize non-invasive healthcare, as a growing number of research facilities and laboratories adopt our genetic tests globally.
Current Opportunities
Speculative Applications
This is an exciting time for Nonacus as the company is continually expanding. Even if you can't see the perfect role right now, we would love to hear from you and keep your CV on file.
If an ideal fit arises, we can then get in contact to let you know about the opportunity in question. We always value great talent.
